| Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. (NCT01301430) | Oryx GmbH & Co. KG | 2011-09-01 |
| PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation (NCT01402063) | Brown University | 2011-09-01 |
| Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma (NCT01386710) | Northwell Health | 2011-09-01 |
| Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients (NCT01508117) | University of Cincinnati | 2011-08-01 |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors (NCT01929720) | Ohio State University Comprehensive Cancer Center | 2011-08-01 |
| A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients (NCT01588769) | CytoVac A/S | 2011-08-01 |
| Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors (NCT02006563) | University of Miami | 2011-06-08 |
| Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) (NCT01110876) | M.D. Anderson Cancer Center | 2011-06-01 |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma (NCT01290692) | TVAX Biomedical | 2011-06-01 |
| A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma (NCT01308684) | Hoffmann-La Roche | 2011-05-01 |
| A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors (NCT01351519) | MultiCare Health System Research Institute | 2011-05-01 |
| Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. (NCT01353625) | Celgene | 2011-04-25 |
| AZD8055 for Adults With Recurrent Gliomas (NCT01316809) | National Cancer Institute (NCI) | 2011-03-04 |
| Vitamin D for Treatment of Glioblastoma Multiforme (NCT01181193) | Soroka University Medical Center | 2011-03-01 |
| A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 (NCT04327011) | Tocagen Inc. | 2011-02-01 |
| (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas (NCT01281982) | National Cancer Institute (NCI) | 2011-01-13 |
| A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM) (NCT01280552) | Precision Life Sciences Group | 2011-01-01 |
| A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme (NCT01268566) | MedImmune LLC | 2011-01-01 |
| Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme (NCT01260506) | Vascular Biogenics Ltd. operating as VBL Therapeutics | 2010-12-01 |
| Amgen 386 for Recurrent Glioblastoma (NCT01290263) | Dana-Farber Cancer Institute | 2010-12-01 |
| Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme (NCT01285414) | Myrexis Inc. | 2010-12-01 |
| Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme (NCT01205334) | Baylor College of Medicine | 2010-11-01 |
| Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA (NCT01269853) | Northwell Health | 2010-10-01 |
| Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status (NCT02898012) | Assistance Publique - Hôpitaux de Paris | 2010-10-01 |
| Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme (NCT01209442) | University of Colorado, Denver | 2010-09-16 |
| Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors (NCT01151670) | Wake Forest University Health Sciences | 2010-08-01 |
| Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA (NCT01180816) | Northwell Health | 2010-08-01 |
| AMG 102 and Avastin for Recurrent Malignant Glioma (NCT01113398) | Katy Peters | 2010-08-01 |
| Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma (NCT01177397) | Celgene | 2010-07-20 |
| Cellular Immunotherapy Study for Brain Cancer (NCT01144247) | Jonsson Comprehensive Cancer Center | 2010-07-01 |
| A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma (NCT00967330) | Hoffmann-La Roche | 2010-06-01 |
| A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme (NCT01115491) | Hoffmann-La Roche | 2010-06-01 |
| Effects of Steroid Tapering on Functional Capacity and Neurocognition (NCT01169415) | Duke University | 2010-06-01 |
| A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas (NCT01117155) | National Cancer Institute (NCI) | 2010-04-23 |
| PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma (NCT01112527) | Massachusetts General Hospital | 2010-04-01 |
| Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma (NCT01081223) | TVAX Biomedical | 2010-04-01 |
| Dendritic Cell Cancer Vaccine for High-grade Glioma (NCT01213407) | Activartis Biotech | 2010-04-01 |
| Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform (NCT01120639) | Stanford University | 2010-04-01 |
| Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors (NCT00943007) | Maastricht University Medical Center | 2010-02-01 |
| BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor (NCT01124461) | Washington University School of Medicine | 2010-01-01 |
| Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas (NCT01317888) | Drexel University | 2010-01-01 |
| Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma (NCT01124539) | Arno Therapeutics | 2009-12-01 |
| APG101 in Glioblastoma (NCT01071837) | Apogenix GmbH | 2009-12-01 |
| Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme (NCT00979017) | Katy Peters | 2009-11-01 |
| Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma (NCT00650949) | Gilead Sciences | 2009-11-01 |
| Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme (NCT00892177) | Alliance for Clinical Trials in Oncology | 2009-10-01 |
| Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients (NCT01135875) | University of Florida | 2009-10-01 |
| Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection (NCT01006044) | Clinica Universidad de Navarra, Universidad de Navarra | 2009-10-01 |
| A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) (NCT00990496) | Milton S. Hershey Medical Center | 2009-09-01 |
| Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma (NCT00879437) | Baylor College of Medicine | 2009-09-01 |
| A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma (NCT01044966) | Medical University of South Carolina | 2009-09-01 |
| A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas (NCT00995007) | National Cancer Institute (NCI) | 2009-09-01 |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) (NCT00968240) | Northwell Health | 2009-07-01 |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma (NCT00734864) | Annick Desjardins | 2009-06-01 |
| Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCT00916409) | NovoCure Ltd. | 2009-06-01 |
| Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme (NCT00984438) | University of Cincinnati | 2009-06-01 |
| Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM (NCT00943462) | Centre hospitalier de l'Université de Montréal (CHUM) | 2009-06-01 |
| Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme (NCT00904852) | Millennium Pharmaceuticals, Inc. | 2009-06-01 |
| Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme (NCT00892931) | Myrexis Inc. | 2009-04-01 |
| Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme (NCT01450449) | International Atomic Energy Agency | 2009-02-01 |
| Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1) (NCT00797940) | Sophiris Bio Corp | 2009-01-01 |
| RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM (NCT00805961) | SCRI Development Innovations, LLC | 2009-01-01 |
| A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) (NCT00735436) | Duke University | 2008-12-01 |
| Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM) (NCT00817284) | Ulrik Lassen | 2008-11-01 |
| A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme (NCT00800917) | Rigshospitalet, Denmark | 2008-11-01 |
| CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme (NCT00768911) | Adnexus, A Bristol-Myers Squibb R&D Company | 2008-10-01 |
| Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme (NCT00730262) | Thallion Pharmaceuticals | 2008-08-01 |
| Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors (NCT00747253) | Monteris Medical | 2008-08-01 |
| A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma (NCT00683761) | TransMolecular | 2008-08-01 |
| A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas (NCT00704080) | Sanofi | 2008-08-01 |
| Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy (NCT00615186) | Bradmer Pharmaceuticals Inc. | 2008-06-01 |
| Sunitinib to Treat Recurrent Brain Cancer (NCT00923117) | National Cancer Institute (NCI) | 2008-06-01 |
| Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme (NCT00704288) | Exelixis | 2008-05-01 |
| Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme (NCT00635557) | Myrexis Inc. | 2008-03-01 |
| Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma (NCT00591058) | TransMolecular | 2008-02-01 |
| Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) (NCT00555399) | M.D. Anderson Cancer Center | 2007-11-28 |
| Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM (NCT00548938) | Methodist Healthcare - Memphis | 2007-10-01 |
| SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme (NCT00535379) | Medical University Innsbruck | 2007-10-01 |
| Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma (NCT00509821) | Eli Lilly and Company | 2007-10-01 |
| Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM) (NCT00515086) | Novartis Pharmaceuticals | 2007-08-01 |
| Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse (NCT00677716) | Peregrine Pharmaceuticals | 2007-07-01 |
| Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma (NCT00501891) | Duke University | 2007-07-01 |
| Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme. (NCT00645385) | Weill Medical College of Cornell University | 2007-06-01 |
| Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors (NCT00441142) | Patrick Y. Wen, MD | 2007-05-25 |
| A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma (NCT00479765) | Boston Scientific Corporation | 2007-03-01 |
| The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas (NCT00473408) | Haukeland University Hospital | 2007-03-01 |
| Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma (NCT00589875) | Candel Therapeutics, Inc. | 2007-03-01 |
| Radiosurgery for Glioblastoma Multiforme (NCT00456612) | Beth Israel Deaconess Medical Center | 2007-02-01 |
| Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme (NCT00590681) | University of Chicago | 2007-02-01 |
| Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients (NCT01089868) | Ludwig-Maximilians - University of Munich | 2007-01-01 |
| Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) | Northwest Biotherapeutics | 2006-12-01 |
| Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma (NCT00409214) | Light Sciences Oncology | 2006-11-01 |
| Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities (NCT00589095) | Yale University | 2006-11-01 |
| AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme (NCT00394628) | Novacea | 2006-10-01 |
| Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients (NCT00402116) | Eli Lilly and Company | 2006-09-01 |
| Radiation Boost for Newly Diagnosed Glioblastoma Multiforme (NCT00376103) | Methodist Healthcare - Memphis | 2006-08-01 |
| Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection (NCT00400322) | Karolinska Institutet | 2006-08-01 |
| Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme (NCT00323115) | Dartmouth-Hitchcock Medical Center | 2006-05-01 |
| Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma (NCT00301418) | Northwell Health | 2006-03-01 |
| Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) (NCT00311857) | Heidelberg University | 2006-02-01 |